Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: The non-steroidal mineralocorticoid receptor antagonist finerenone and heart failure with preserved ejection fraction

Fig. 2

Cardioprotective actions of Finerenone in HFpEF. MR: mineralocorticoid receptor; E: early diastolic flow velocity; e’: velocity of early diastolic mitral annular motion; IVRT: isovolumic relaxation time; GLS: global longitudinal strain; LVEDP: left ventricular end-diastolic pressure.

[adapted from “Mast Cell Key Features” template, by BioRender.com (2022). Retrieved from https://app.biorender.com/biorender-templates]

Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840